P91 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - PTC Therapeutics Inc

Watchlist Manager

Watchlist

Price: 43.8 EUR 1.86% Market Closed

Market Cap: €3.1B

P	PTC Therapeutics Inc F:P91	US
C	Continental AG F:CON	DE
A	Aspen Pharmacare Holdings Ltd SWB:LDZA	ZA
N	Nucor Corp XMUN:NUO	US
S	Stora Enso Oyj XMUN:ENUA	FI
A	Anhui Conch Cement Co Ltd OTC:AHCHF	CN
A	Advanced Micro Devices Inc MIL:1AMD	US
	Saipem SpA F:SPE1	IT
C	CENIT AG SWB:CSH	DE
J	JCDecaux SE XMUN:DCS	FR
	Tiny Ltd TSX:TINY	CA
E	Experian PLC XMUN:J2B	IE
C	Chipotle Mexican Grill Inc F:C9F	US

Profitability Summary

PTC Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

93%

Strong 3Y Average Gross Margin

82%

Declining Gross Margin

94% > 93%

Healthy Operating Margin

12%

Low 3Y Average Operating Margin

Operating Margin is Increasing

-42% > 12%

Negative Net Margin

-4%

Negative 3Y Average Net Margin

-13%

Net Margin is Increasing

-75% > -4%

Negative Free Cash Flow Margin

-4%

Strong 3Y Average Free Cash Flow Margin

29%

Free Cash Flow Margin is Increasing

-39% > -4%

Positive ROE

21%

Positive 3Y Average ROE

Positive 3Y Average ROIC

24%

ROIC is Increasing

-30% > 9%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.